Coffee Talk (itch) Mac OS

Expires On
April 28, 2021

You play as a farmer who has been living peacefully with family. There is no purpose of it in the beginning, MC lives his daily life with Elly, and visits villages when he has time. Find the best information and most relevant links on all topics related toThis domain may be for sale!

Completion Time
60 minutes

Specialty
Dermatology, Education, Integrative Medicine, Obstetrics & Gynecology, Pathology, Primary Care, Radiology, Surgery

Scroll to the Bottom of this Information to Begin this Course

This activity is Physicians’ Education Resource®, LLC.

Supported by an educational grant from Allergan.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This education activity is directed towards OB-GYNs, medical oncologists, surgical oncologists, radiation oncologists, primary care physicians, such as family practitioners and internists, and radiologists.

Program Overview

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma and is a distinct entity from systemic ALCL. In the United States, the FDA began to recognize reports of ALCL and a potential association with breast implants in 2011, and subsequently started a collaboration with the American Society of Plastic Surgeons (ASPS) and the Plastic Surgery Foundation (PSF) to create the Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma (ALCL) Etiology and Epidemiology (PROFILE Registry). Incidence has been associated with the textured surface of the implant and is highest in the more highly textured (ie, greater surface area) implants. Reports indicate that the majority of cases, if diagnosed quickly, are limited to effusion around the implant and can frequently be effectively treated with surgical intervention without the need for adjuvant systemic therapy. However, given the recent history of BIA-ALCL and the infrequency of incidence, physicians who see patients at first presentation of disease are unlikely to be familiar with symptoms.

This Community Practice Connection™ program is designed to assist clinicians in keeping up to date on developments in the recently defined malignancy BIA-ALCL. This online program will provide a comprehensive review of BIA-ALCL, including epidemiology, presentation, diagnosis, and treatment strategies. Integrated expert video interviews will highlight the practical application of recent data that directly influence treatment guidelines and best practices to help you provide optimal care to your patients.

Learning Objectives

Upon completion of this activity, you should be better prepared to:

Coffee talk (itch) mac os sierra
  • Describe presenting symptoms of BIA-ALCL and how to distinguish this cancer from other breast implant problems
  • Discuss the incidence and prevalence of BIA-ALCL and the need for centralized reporting
  • Identify best practices in BIA-ALCL treatment and discuss evidence available for treatment options
  • Detail a treatment strategy that incorporates a multidisciplinary team to optimize outcomes for patients with BIA-ALCL

Faculty

Lloyd B. Gayle, MD, FACS

Chief of Plastic Surgery and Vice Chair of Surgery
Maimonides Medical Center
Clinical Associate Professor of Surgery
Weill Medical College of Cornell University
New York, NY

Peter G. Cordeiro, MD, FACS

Reconstructive Surgeon
William G. Cahan Chair in Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Martin C. Mahoney, MD, PhD

Professor of Oncology
Roswell Park Comprehensive Cancer
Buffalo, NY

Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Lloyd B. Gayle, MD, FACS

  • Has no relevant financial relationships with commercial interests to disclose.

Peter G. Cordeiro, MD, FACS

  • Has no relevant financial relationships with commercial interests to disclose.

Martin C. Mahoney, MD, PhD

Coffee Talk (itch) Mac Os Catalina

  • Has no relevant financial relationships with commercial interests to disclose.

Coffee Talk (itch) Mac Os Catalina

The staff of Physicians’ Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Instructions for Participation and Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video” will be available for your reference.
  • In order to receive a CME Certificate, you must complete the activity.
  • Complete the Posttest and the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

Coffee Talk (itch) Mac Os Download

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Coffee Talk (itch) Mac Os X

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.